Susan K. Sullivan - Concepedia

Author

Susan K. Sullivan

Neurocrine Biosciences (United States)

Also Known As

S Sullivan, S. SULLIVAN, S.K Sullivan, Susan K Sullivan, Susan K. Sullivan, Susan Kruse Sullivan, Susan Sullivan

Publications

584

Citations

H-Index

Concepts

All Affiliations

Neurocrine Biosciences (United States)

About

Susan K. Sullivan is an author at Neurocrine Biosciences (United States) specializing in medicine, pharmacology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	448
2	Natural Sciences	5	5	135
3	Engineering	1	1	16
4	Health Sciences	1	1	17
5	Public Health	1	1	34

Susan K. Sullivan

Publications

584

Citations

H-Index

Page 1

	Year	Citations
Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity Sam R.J. Hoare, Susan K. Sullivan, Jun Fan, Peptides Signal TransductionPeptide LigandFunctional SelectivityMedicineG Protein-coupled Receptor	2004	62
Characterization of the Interaction of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic, with the GABAA Receptor Susan K. Sullivan, Robert E. Petroski, Gail Verge, Journal of Pharmacology and Experimental Therapeutics	2004	55
Molecular Determinants of Receptor Binding and Signaling by the CX3C Chemokine Fractalkine Laura S. Mizoue, Susan K. Sullivan, David S. King, Journal of Biological Chemistry Molecular BiologyChemical BiologyCellular PhysiologySignaling PathwayReceptor Tyrosine Kinase	2001	52
MIP-3α induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK) Susan K. Sullivan, Douglas A. McGrath, Fang Liao, Journal of Leukocyte Biology Mip-3alpha-induced Signal TransductionMitogen-activated Protein KinasesMolecular RegulationImmunologyIntracellular Calcium Mobilization	1999	49
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines Shiwang Chen, Kevin B. Bacon, Gabriela García, Transplantation Proceedings Cell TherapyTransplantationLymphocyte Migratory ResponsesMedicineCell Trafficking	2001	47
Selection, synthesis, and structure–activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists Marion Lanier, Miklós Fehér, Neil J. Ashweek, Bioorganic & Medicinal Chemistry Structure–activity RelationshipBiochemistryMedicineNatural SciencesNon-peptide Ligand	2007	41
Pharmacological and Signaling Analysis of Human Chemokine Receptor CCR-7 Stably Expressed in HEK-293 Cells: High-Affinity Binding of Recombinant Ligands MIP-3β and SLC Stimulates Multiple Signaling Cascades Susan K. Sullivan, Douglas A. McGrath, Dimitri E. Grigoriadis, Biochemical and Biophysical Research Communications Molecular PhysiologySignal TransductionChemokine BiologyHek-293 CellsSignaling Pathway	1999	39
Pharmacological Characterization of a Novel Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor, NBI-42902 R. Scott Struthers, Qui Xie, Susan K. Sullivan, Endocrinology Hormonal ContraceptivePharmacological CharacterizationEndocrine MechanismFunctional SelectivityMedicine	2006	36
Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure–activity relationships and insurmountable antagonism Susan K. Sullivan, Sam R.J. Hoare, Beth A. Fleck, Biochemical Pharmacology Molecular PharmacologyInsurmountable AntagonismNonpeptide AntagonistBiochemistryEndocrine Mechanism	2006	34
Human Thymocytes Express CCR-3 and Are Activated by Eotaxin Karin Franz-Bacon, Daniel J. Dairaghi, Stefen A. Boehme, Blood	1999	33

Page 1